Biomol Ther.  2014 May;22(3):254-259.

Enhancement of Platelet Aggregation by Ursolic Acid and Oleanolic Acid

• Kim M
• Han CH
• Lee MY

Abstract

The pentacyclic triterpenoid ursolic acid (UA) and its isomer oleanolic acid (OA) are ubiquitous in food and plant medicine, and thus are easily exposed to the population through natural contact or intentional use. Although they have diverse health benefits, reported cardiovascular protective activity is contentious. In this study, the effect of UA and OA on platelet aggregation was examined on the basis that alteration of platelet activity is a potential process contributing to cardiovascular events. Treatment of UA enhanced platelet aggregation induced by thrombin or ADP, which was concentration-dependent in a range of 5-50 microM. Quite comparable results were obtained with OA, in which OA-treated platelets also exhibited an exaggerated response to either thrombin or ADP. UA treatment potentiated aggregation of whole blood, while OA failed to increase aggregation by thrombin. UA and OA did not affect plasma coagulation assessed by measuring prothrombin time and activated partial thromboplastin time. These results indicate that both UA and OA are capable of making platelets susceptible to aggregatory stimuli, and platelets rather than clotting factors are the primary target of them in proaggregatory activity. These compounds need to be used with caution, especially in the population with a predisposition to cardiovascular events.

Keyword

Ursolic acid; Oleanolic acid; Platelet aggregation

MeSH Terms

Adenosine Diphosphate
Blood Platelets
Insurance Benefits
Oleanolic Acid*
Partial Thromboplastin Time
Plants
Plasma
Platelet Aggregation*
Prothrombin Time
Thrombin
Adenosine Diphosphate
Oleanolic Acid
Thrombin